Enterprise Value to EBITDA Multiple ratio Analysis of Orion Biotech Opp Corp. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-22
Poor EV to EBITDA
23.37
Period Ending - Dec-21
Very Poor EV to EBITDA
-352.02
Growth
106.64 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-22
Excellent EV to EBITDA
0.0000
EV to EBITDA Analysis of Orion Biotech Opp Corp.
| Enterprise Value to EBITDA of Orion Biotech Opp Corp. with value of 23.37 implies that the company is overvalued. |
| EV to EBITDA Ratio of ORIA rose handsomely by 106.64 % this year. |
Other EV to EBITDA Related Info of ORIA that may interest you.
Orion Biotech Opp Corp. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ORIA | 10.23 | 10.23 | 0 % | Shell Companies |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Good Value | |
FY - Historical Enterprise Value to EBITDA Multiple of Orion Biotech Opp Corp.
| Period | Dec-22 | Dec-21 |
|---|---|---|
| EV to EBITDA | 23.37 | -352.02 |
| Change | 106.64 % |
FY Chart of Enterprise Value to EBITDA Multiple of Orion Biotech Opp Corp.
Note : All Data Generated at the End of Trading Hours (EOD Data)